Evidence map›Paper›PMID 37523589›Full record

ReviewThe Journal of international medical research2023

Application of biomaterials and nanotechnology in corneal tissue engineering.

Mohammad Soleimani, Zohreh Ebrahimi, Kosar Sadat Ebrahimi, Negin Farhadian, Mohsen Shahlaei, Kasra Cheraqpour, Hamed Ghasemi, Sajad Moradi, Arthur Y Chang, Sina Sharifi and 2 more

Abstract readReview
In one paragraph

Review in The Journal of international medical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Advancements in keratoplasty: Exploring newer techniques and imaging modalities for enhanced surgical outcomes.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mohammad SoleimaniEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-6546-3546
Zohreh EbrahimiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Kosar Sadat EbrahimiNano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Negin FarhadianSubstance Abuse Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Mohsen ShahlaeiNano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Kasra CheraqpourEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-1273-9166
Hamed GhasemiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Sajad MoradiNano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Arthur Y ChangDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.
Sina SharifiSchepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Boston, MA, USA.
Seyed Mahbod BaharnooriEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ali R DjalilianDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corneal diseases are among the most common causes of blindness worldwide. Regardless of the etiology, corneal opacity- or globe integrity-threatening conditions may necessitate corneal replacement procedures. Several procedure types are currently available to address these issues, based on the complexity and extent of injury. Corneal allograft or keratoplasty is considered to be first-line treatment in many cases. However, a significant proportion of the world's population are reported to have no access to this option due to limitations in donor preparation. Thus, providing an appropriate, safe, and efficient synthetic implant (e.g., artificial cornea) may revolutionize this field. Nanotechnology, with its potential applications, has garnered a lot of recent attention in this area, however, there is seemingly a long way to go. This narrative review provides a brief overview of the therapeutic interventions for corneal pathologies, followed by a summary of current biomaterials used in corneal regeneration and a discussion of the nanotechnologies that can aid in the production of superior implants.

Indexed as

Corneal DiseasesTissue EngineeringBiocompatible MaterialsCorneaHumansNanotechnologyBiocompatible MaterialsBioengineeringBiopolymerCorneal donorCorneal transplantationKeratoplastyNanotechnology

Identifiers

PMID37523589
PMCPMC10392709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.